Instruction to Authors
Aims & Scope: Journal of Babol University of Medical Sciences scheduled to appear monthly and publish scientific Journal in the fields of medicine. This Journal accepts original article, review article and case report written in Persian with English abstract.
Submission: The manuscript has to be submitted online via our online submission service www.mubabol.ac.ir. Each manuscript must be accompanied by a covering letter to the Editor in Chief, signed by all authors, stating that the authors wish to have their paper evaluated for publication in the Journal of Babol University of Medical Sciences and that no substantial part has been, or will be published elsewhere. Accepted manuscripts are published in the order of receipt of the final approved version, after review, revision. Authors are responsible for all statements made in their work. Manuscript should be typed in double space (1.2 cm) on one side of the A4 size paper with 2.5 cm margins on both sides. Manuscript should be typed in Microsoft word 2002 or newer. English text should be submitted in Times New Roman font, 10 point type. The manuscript should contain Running title (maximum 50 characters) in the top of each page. Manuscript should include Title page, Abstract, Keywords, Introduction, Materials & Methods, Results, Discussion, Acknowledgement, References.
Original Article: Original investigations are considered full-length applied (human) or basic (bench work) research reports. Body of manuscript should include Title Page, Structured Abstract, Introduction, Method and Material (including statistical methods used), Findings, Limitation (if need), Conclusion, Acknowledgments, References, Illustrations (if applicable). The number of research papers should not exceed 2500 words.
Case Reports : Case Reports include case studies of patient(s) that describe a novel situation or add important insights into mechanisms, diagnosis or treatment of a disease. Body of Case Report manuscript should include: Title Page, Structured Abstract, Introduction, Case presentation, Conclusion, Acknowledgments, References, and Photos (if applicable). The number of case reports should not exceed 2000 words.
Review Article: Review articles should have at least 50 references. Authors should use at least 3-5 references of their own prior work. The number of review articles should not exceed 3000 words.
Title Page: The complete title of the manuscript, the name of all the authors with their highest academic degrees, the department or institution to which they are attached, address for correspondence with telephone numbers, e-mail and Fax number.
Abstract: All original articles must accompany a structured abstract up to 250 words. It should be structured as Background, Methods, Results and Conclusion followed by 3 to 5 Keywords.
Introduction: This should summarize the purpose and the rationale for the study. It should neither review the subject extensively nor should it have data or conclusions of the study.
Materials & Methods: This should include exact method or observation or experiment. If an apparatus is used, its manufacturer's name and address should be given in parenthesis. If the method is established, give reference but if the method is new, give enough information so that another author is able to perform it. If a drug is used, its generic name, dose and route of administration must be given. For patients, ages, sex, with mean age ± standard deviation must be given. Statistical method must be mentioned and specify any general computer program used. The Info system used should be clearly mentioned. Clinical trial should be approved by ethics committee of that organization. Please state that informed consent was obtained from all human adult participants and from the parents or legal guardians of minors. Include the name of the appropriate institutional review board that approved the project. Indicate in the text that the maintenance and care of experimental animals complies with National Institute of Health guidelines for the human use of laboratory animals, or those of your institute or agency. In clinical trial, it is especially important to state how the participants were recruited in the study. In doing this, the sampling frame should be spelt out. As readers like to be assured that the welfare and rights of the participants in the study were placed above those of the investigator.
Ethical Considerations: The ethical principles regarding experiments and researches should be based on Helsinki declaration and 26 codes of ethics in Islamic Republic of Iran.
Results: It must be presented in the form of text, tables and illustrations. The contents of the tables should not be all repeated in the text. Instead, a reference to the table number may be given. Long articles may need sub-headings within some sections to clarify their contents.
Discussion: This should emphasize the present findings and the variations or similarities with other work done in the field by other workers. The detailed data should not be repeated in the discussion again. Emphasize the new and important aspects of the study and the conclusions that follow from them. It must be mentioned whether the hypothesis mentioned in the articles in true, false or no conclusions can be derived. Finally conclusion should be written.
All persons who have made significant contributions should be offered the opportunity to be listed as authors . Author ship credit requires substantial contributions to: 1) conception and design, data acquisitions, or analysis and interpretation of data; 2) drafting the article and providing critical review for important intellectual content; 3) giving final approval of publication. Group members who do not meet these criteria should be acknowledged.
Acknowledgement: All contributors who do not meet the criteria for authorship should be covered in the acknowledgement section. It should include persons who provided technical help, writing assistance and departmental head who only provided general support. Financial and material support should also be acknowledged.
Tables: In limited numbers should be submitted with the captions placed above. Do not submit tables as photograph. Place explanatory matters in footnotes, not in the heading.
Figures: Figures should be in limited numbers, with high quality art work and mounted on separate pages. The captions should be placed below. The same data should not be presented in tables, figures and text, simultaneously.
References: In the text, reference citations should be typed inside parenthesis, e.g. (1). References should be numbered consecutively with Vancouver style. Please list the first three authors for each reference and then et al, unless there are six authors or fewer, in which case all authors should be listed. Provide full reference details (author(s), title, journal, year, volume, pages). Capitalize the first letter and all initials of authors’ names, the first letter of the title of the paper, and any proper nouns in the title. Journal names should be abbreviated as in the Index Medicus. Also, authors can use the articles as reference which published by Journal of Babol University of Medical Sciences.
References should be structured as follows:
Article: Matsumura S, Oue N, Nakayama H, et al. A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol 2005;131(1):19-25.
Books: Harvet RA, Champe PC. Pharmacology. 2nd ed. London: J.B. Lippincott Co 1997; pp: 83-95.
Chapters in Book:
Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and management. 2nd ed. New York: Raven Press 1995; pp: 465-78.
Peer review Process: All manuscripts are considered to be confidential. They are peer reviewed by anonymous reviewers selected by the Editorial Board. The corresponding author is notified as soon as possible of the editor decision to accept, reject, or require modifications.
Conflict of Interest: Authors should disclose at the time of submission any commercial affiliations or other interests that may influence the manuscript. These include patent-licensing agreements, stock ownership, and sources of funding for the study, corporate sponsorship, consultancies, and institutional affiliations.
Copyright: To publish and disseminate articles, the publisher need publishing rights. This is determined by a publishing agreement between the author and the journal. This agreement deals with the transfer or license of the copyright to the journal and authors retain significant rights to use and share their own published articles. By accepting the terms and conditions of each submission electronically or manually during the submission, all authors accepts copyright conditions and terms of the journal. In this case authors have the right to:
- Share their article in the same ways permitted to third parties under the relevant user license (together with Personal Use rights) so long as it contains a CrossMark logo or publisher logo, the end user license, and a DOI link to the version of record on any other sources.
- Retain patent, trademark and other intellectual property rights (including raw research data).
- Proper attribution and credit for the published work.
- Personal Use: Use by an author in the author's classroom teaching (including distribution of copies, paper or electronic), distribution of copies to research colleagues for their personal use, use in a subsequent compilation of the author's works, inclusion in a thesis or dissertation, preparation of other derivative works such as extending the article to book-length form, or otherwise using or re-using portions or excerpts in other works (with full acknowledgment of the original publication of the article).
- Permitted Scholarly Posting: Voluntary posting of published article by an author on open Web sites for Commercial Use or Systematic Distribution is not permitted. Deposit in or posting to subject-oriented repositories (such as PubMed Central), or institutional repositories with mandates for systematic postings, is permitted only under specific agreements between the publisher and the repository, agency or institution, and only consistent with the Copyright Owner's policies concerning such repositories.
Rights granted to Publisher
For open access articles, published in proprietary titles, Publisher is granted the following rights:
- The exclusive right to publish and distribute an article, and to grant rights to others, including for commercial purposes.
- The right to provide the article in all forms and media so the article can be used on the latest technology even after publication.
- The authority to enforce the rights in the article, on behalf of an author, against third parties, for example in the case of plagiarism or copyright infringement.
The Journal of Babol University of Medical Sciences is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Open access statement
This journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and to use them for any other lawful purpose.
Reprint: Three copies of the Journal will be provided to the corresponding author after the publication.
· All clinical trials that are conducted in Iran should have registration with IRCT.
The Editorial Board of the journal, reserves the right to accept or reject the article in any stage and any time or delete a part of the text, tables or figures, if necessary.
Article charges: This journal does not recieve any charges from authors for publishing articles.